Lumipulse™ Human Amyloid Beta (1-40) Detection Kit
Neurodegenerative disease test kit; for total tau protein; cerebrospinal fluid; CE marked
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Description
The Lumipulse Gβ-amyloid protein 1-40 analysis method is designed to be used in conjunction with the Lumipulse Gβ-amyloid protein 1-42 analysis method to determine the ratio of amyloid in the clinical environment (β-amyloid protein 1-42 /β-amyloid protein Like protein 1-40). Diagnose dementia.
The CSF amyloid ratio (β-amyloid 1-42/β-amyloid 1-40 ratio) is intended to be used as a diagnostic aid for patients with cognitive impairment who are undergoing Alzheimer's disease (AD ) And other assessments of cognitive decline.
The CSF amyloid ratio is only used as an adjunct to other diagnostic evaluations, supporting the possibility of AD pathology.
Sample Type
Formulation
Research Use Only
Publications (0)